Goldman Sachs
QGENF

Goldman Sachs’s QIAGEN NV QGENF Stock Holding History

Goldman Sachs’s Portfolio QGENF Stock Details QGENF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-32,400
Closed -$908K – 7306
2016
Q4 		$908K Buy
+32,400
New +$908K ﹤0.01% 4540
2016
Q3 		– Sell
-41,600
Closed -$907K – 7480
2016
Q2 		$907K Buy
+41,600
New +$907K ﹤0.01% 4279
2016
Q1 		– Sell
-9,300
Closed -$257K – 7700
2015
Q4 		$257K Sell
9,300
-57,600
-86% -$1.59M ﹤0.01% 5489
2015
Q3 		$1.73M Sell
66,900
-12,700
-16% -$328K ﹤0.01% 3948
2015
Q2 		$1.97M Buy
79,600
+40,800
+105% +$1.01M ﹤0.01% 3836
2015
Q1 		$978K Buy
+38,800
New +$978K ﹤0.01% 4510
2014
Q3 		– Sell
-76,800
Closed -$1.88M – 7540
2014
Q2 		$1.88M Buy
+76,800
New +$1.88M ﹤0.01% 4049

Other funds holding QGENF

BJCM
Blue Jay Capital Management Los Angeles, California $147M AUM 64.18% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Capital Fund Management (CFM)
Capital Fund Management (CFM) Paris, France $22.1B AUM 20.49% 1-Year Est. Return
Twin Tree Management
Twin Tree Management Dallas, Texas $4.75B AUM 58.16% 1-Year Est. Return

Goldman Sachs's QGENF Position: Q1 2017 in Review

Goldman Sachs sold out of QIAGEN NV (QGENF) in Q1 2017, closing a stake of 1,729,001 shares — an estimated $48.4M sold.

Goldman Sachs first reported a position in QGENF in Q2 2013 and held it in 15 quarters. The position peaked at $48.4M in Q4 2016. 6 funds tracked by Wall St. Rank hold QGENF as of Q1 2017.

  • Goldman Sachs reported no remaining QIAGEN NV position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 1,729,001 QIAGEN NV shares in Q1 2017, an estimated $48.4M.
  • Goldman Sachs first reported a position in QIAGEN NV in Q2 2013 and held it in 15 quarters.
  • Goldman Sachs's QIAGEN NV position peaked at $48.4M in Q4 2016.
  • 6 funds tracked by Wall St. Rank held QIAGEN NV as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.